Money from Sick People Part III: Why is U.S. drug pricing policy designed to exploit patients?
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, 340B, Medicaid, McKesson, pharmacy
How money from sick people works, Part II: The 340B story
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, CVS, 340B, Medicaid, McKesson, pharmacy
How low can you go? Newly launched dashboard explores 340B’s deeply discounted drug prices
Examining the first month of 2022 brand drug price increases
Ben LinkBrand drugs, List prices, WAC, Rebates, Aduhelm, Medicaid, AbbVie, Humira, Biktarvy, Vyvanse, Auvi-Q, Biogen, Micardis, Admelog, Insulin
Flash finding: How drug money from sick people really works
Drugmakers break record for most January list price increases in a decade
Ben LinkNADAC, Medicaid, Generic, Semglee, Basaglar, Albendazole, Part D, Eliquis, Grassley, Wyden, Insulin, Mycophenolic Acid, Dalfampridine, clobazam, cincacalcet, Mark Cuban, acetaminophen, lansoprazole ODT, lamotrigine, Clonidine, atomoxetine
It's not just insulin: Comparing the cost of diabetes treatment in Canada versus the U.S.
Ben LinkWAC, List prices, Medicaid, Insulin, Diabetes, Canada, International pricing, Eliquis, Ohio, Eli Lilly, Pradaxa, Xarelto
